Eagle's Eye View: Your Weekly CV Update From ACC.org cover image

Eagle’s Eye View: Saturday, November 11 — Daily Wrap Up | AHA 2023

Eagle's Eye View: Your Weekly CV Update From ACC.org

00:00

Introduction

Experts discuss the top-line results of the select trial, which showed a 20% reduction in cardiovascular death, myocardial infarction, and stroke with the use of semaglutide in obese patients with cardiovascular disease.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app